Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Angiography | 83 | 2020 | 1434 | 6.290 |
Why?
|
Magnetic Resonance Imaging, Cine | 62 | 2024 | 1092 | 5.030 |
Why?
|
Echocardiography | 64 | 2024 | 5044 | 4.520 |
Why?
|
Magnetic Resonance Imaging | 164 | 2024 | 36849 | 3.370 |
Why?
|
Ventricular Function, Left | 49 | 2024 | 3941 | 3.300 |
Why?
|
Coronary Vessels | 63 | 2020 | 3125 | 3.280 |
Why?
|
Heart Atria | 35 | 2024 | 1360 | 3.110 |
Why?
|
Atrial Fibrillation | 50 | 2022 | 5168 | 2.640 |
Why?
|
Image Enhancement | 56 | 2021 | 2894 | 2.480 |
Why?
|
Cardiology | 23 | 2022 | 1701 | 2.390 |
Why?
|
Heart Ventricles | 37 | 2024 | 3838 | 2.320 |
Why?
|
Ventricular Dysfunction, Left | 23 | 2024 | 2144 | 2.260 |
Why?
|
Hypertrophy, Left Ventricular | 24 | 2019 | 856 | 2.250 |
Why?
|
Atrial Appendage | 7 | 2016 | 285 | 2.140 |
Why?
|
Gadolinium | 27 | 2024 | 965 | 2.140 |
Why?
|
Pulmonary Veins | 17 | 2016 | 754 | 2.130 |
Why?
|
Echocardiography, Transesophageal | 26 | 2022 | 1095 | 2.040 |
Why?
|
Image Interpretation, Computer-Assisted | 36 | 2022 | 3411 | 1.990 |
Why?
|
Cardiomyopathy, Hypertrophic | 31 | 2024 | 1335 | 1.970 |
Why?
|
Contrast Media | 59 | 2024 | 5336 | 1.850 |
Why?
|
Stroke Volume | 41 | 2024 | 5619 | 1.820 |
Why?
|
Imaging, Three-Dimensional | 47 | 2019 | 4076 | 1.740 |
Why?
|
Heart | 45 | 2023 | 4449 | 1.640 |
Why?
|
Aortic Valve Insufficiency | 6 | 2020 | 577 | 1.610 |
Why?
|
Respiratory-Gated Imaging Techniques | 10 | 2022 | 75 | 1.470 |
Why?
|
Aortic Diseases | 12 | 2022 | 741 | 1.460 |
Why?
|
Cicatrix | 16 | 2023 | 799 | 1.430 |
Why?
|
Electric Countershock | 14 | 2013 | 534 | 1.400 |
Why?
|
Gadolinium DTPA | 23 | 2017 | 823 | 1.370 |
Why?
|
Myocardium | 37 | 2024 | 4788 | 1.360 |
Why?
|
Predictive Value of Tests | 66 | 2024 | 15455 | 1.350 |
Why?
|
Mitral Valve Insufficiency | 12 | 2022 | 1414 | 1.350 |
Why?
|
Editorial Policies | 6 | 2022 | 459 | 1.340 |
Why?
|
Echocardiography, Doppler | 10 | 2019 | 899 | 1.340 |
Why?
|
Heart Diseases | 24 | 2019 | 2819 | 1.310 |
Why?
|
Cardiovascular Diseases | 32 | 2022 | 15649 | 1.310 |
Why?
|
Coronary Angiography | 37 | 2020 | 4537 | 1.300 |
Why?
|
Takotsubo Cardiomyopathy | 2 | 2020 | 125 | 1.240 |
Why?
|
Atrial Function, Left | 6 | 2018 | 188 | 1.230 |
Why?
|
Aorta, Thoracic | 15 | 2024 | 1112 | 1.180 |
Why?
|
Periodicals as Topic | 7 | 2021 | 1469 | 1.160 |
Why?
|
Papillary Muscles | 9 | 2024 | 192 | 1.130 |
Why?
|
Coronary Disease | 25 | 2022 | 5924 | 1.090 |
Why?
|
Aorta, Abdominal | 9 | 2013 | 627 | 1.050 |
Why?
|
Thromboembolism | 10 | 2014 | 1004 | 1.050 |
Why?
|
Accreditation | 3 | 2019 | 478 | 0.990 |
Why?
|
Ventricular Remodeling | 12 | 2020 | 1281 | 0.990 |
Why?
|
Organometallic Compounds | 13 | 2019 | 648 | 0.990 |
Why?
|
Artifacts | 25 | 2021 | 1930 | 0.980 |
Why?
|
Cardiomyopathy, Dilated | 9 | 2024 | 843 | 0.960 |
Why?
|
Aortic Valve Stenosis | 7 | 2017 | 2034 | 0.960 |
Why?
|
Tricuspid Valve Insufficiency | 4 | 2022 | 362 | 0.940 |
Why?
|
Meglumine | 8 | 2019 | 144 | 0.920 |
Why?
|
Coronary Artery Disease | 26 | 2022 | 6567 | 0.890 |
Why?
|
Catheter Ablation | 13 | 2018 | 2776 | 0.880 |
Why?
|
Humans | 411 | 2024 | 768393 | 0.880 |
Why?
|
Incidental Findings | 4 | 2014 | 698 | 0.850 |
Why?
|
Ventricular Function, Right | 6 | 2020 | 628 | 0.830 |
Why?
|
Image Processing, Computer-Assisted | 43 | 2017 | 9063 | 0.830 |
Why?
|
Electrocardiography | 36 | 2023 | 6409 | 0.810 |
Why?
|
Reproducibility of Results | 63 | 2024 | 20224 | 0.810 |
Why?
|
Middle Aged | 202 | 2024 | 223491 | 0.780 |
Why?
|
Sensitivity and Specificity | 52 | 2020 | 14737 | 0.780 |
Why?
|
Male | 267 | 2024 | 364902 | 0.780 |
Why?
|
Myocardial Contraction | 8 | 2019 | 1527 | 0.770 |
Why?
|
Aortic Valve | 7 | 2019 | 1969 | 0.760 |
Why?
|
Female | 265 | 2024 | 397089 | 0.760 |
Why?
|
Warfarin | 11 | 2015 | 1493 | 0.730 |
Why?
|
Aged | 155 | 2024 | 171562 | 0.720 |
Why?
|
Biomedical Research | 4 | 2021 | 3464 | 0.720 |
Why?
|
Cardiomyopathies | 8 | 2024 | 2056 | 0.710 |
Why?
|
Syncope | 2 | 2020 | 430 | 0.710 |
Why?
|
Mitral Valve Prolapse | 7 | 2020 | 213 | 0.710 |
Why?
|
Pulmonary Embolism | 8 | 2024 | 2587 | 0.700 |
Why?
|
Respiration | 21 | 2021 | 1667 | 0.700 |
Why?
|
Mitral Valve | 8 | 2017 | 1474 | 0.650 |
Why?
|
Ventricular Dysfunction, Right | 3 | 2022 | 644 | 0.640 |
Why?
|
Coronary Vessel Anomalies | 6 | 2003 | 308 | 0.640 |
Why?
|
Diaphragm | 5 | 2013 | 359 | 0.630 |
Why?
|
Aortography | 2 | 2019 | 422 | 0.620 |
Why?
|
Journal Impact Factor | 5 | 2021 | 156 | 0.610 |
Why?
|
Bundle-Branch Block | 2 | 2018 | 278 | 0.610 |
Why?
|
Pericardium | 7 | 2018 | 679 | 0.610 |
Why?
|
Coronary Aneurysm | 6 | 2008 | 234 | 0.610 |
Why?
|
Adult | 175 | 2024 | 223640 | 0.610 |
Why?
|
Myocardial Infarction | 17 | 2022 | 11516 | 0.600 |
Why?
|
Defibrillators, Implantable | 9 | 2024 | 1498 | 0.600 |
Why?
|
Cardiac Imaging Techniques | 2 | 2017 | 281 | 0.570 |
Why?
|
Algorithms | 27 | 2022 | 14154 | 0.570 |
Why?
|
Coronary Thrombosis | 6 | 2013 | 440 | 0.560 |
Why?
|
Thrombosis | 12 | 2016 | 2955 | 0.560 |
Why?
|
Arteriosclerosis | 8 | 2004 | 1056 | 0.560 |
Why?
|
Outpatients | 3 | 2015 | 1604 | 0.540 |
Why?
|
Fibrosis | 17 | 2024 | 2077 | 0.540 |
Why?
|
Cardiac-Gated Imaging Techniques | 8 | 2014 | 139 | 0.540 |
Why?
|
Anticoagulants | 12 | 2015 | 4843 | 0.530 |
Why?
|
Guideline Adherence | 5 | 2015 | 2240 | 0.530 |
Why?
|
Clinical Competence | 6 | 2021 | 4848 | 0.520 |
Why?
|
Reference Values | 17 | 2024 | 4941 | 0.520 |
Why?
|
Coronary Circulation | 9 | 2014 | 1617 | 0.520 |
Why?
|
Phantoms, Imaging | 20 | 2021 | 2528 | 0.510 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3118 | 0.510 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3241 | 0.510 |
Why?
|
Prognosis | 33 | 2024 | 30022 | 0.490 |
Why?
|
Respiratory Mechanics | 6 | 2014 | 722 | 0.490 |
Why?
|
Blood Flow Velocity | 7 | 2021 | 1376 | 0.480 |
Why?
|
Heart Murmurs | 1 | 2015 | 92 | 0.480 |
Why?
|
Aging | 6 | 2014 | 8764 | 0.480 |
Why?
|
Observer Variation | 10 | 2019 | 2623 | 0.480 |
Why?
|
Coronary Stenosis | 7 | 2020 | 802 | 0.480 |
Why?
|
Systole | 6 | 2017 | 937 | 0.480 |
Why?
|
Heart Valve Diseases | 4 | 2017 | 1030 | 0.470 |
Why?
|
Atrial Flutter | 3 | 2014 | 253 | 0.470 |
Why?
|
Pulmonary Edema | 1 | 2017 | 409 | 0.460 |
Why?
|
Aged, 80 and over | 49 | 2024 | 59686 | 0.450 |
Why?
|
Pacemaker, Artificial | 2 | 2017 | 828 | 0.450 |
Why?
|
Pattern Recognition, Automated | 4 | 2014 | 998 | 0.450 |
Why?
|
Patient Care | 1 | 2019 | 629 | 0.440 |
Why?
|
Heart Failure | 15 | 2024 | 11858 | 0.430 |
Why?
|
Heart Valves | 1 | 2015 | 284 | 0.430 |
Why?
|
Body Size | 2 | 2014 | 463 | 0.430 |
Why?
|
Nuclear Medicine | 2 | 2014 | 262 | 0.420 |
Why?
|
Myocardial Stunning | 3 | 2014 | 67 | 0.420 |
Why?
|
Tomography, X-Ray Computed | 22 | 2024 | 20765 | 0.420 |
Why?
|
Stroke | 10 | 2022 | 9742 | 0.420 |
Why?
|
Myocarditis | 1 | 2020 | 803 | 0.410 |
Why?
|
Internship and Residency | 3 | 2022 | 5949 | 0.400 |
Why?
|
Echo-Planar Imaging | 9 | 2002 | 669 | 0.400 |
Why?
|
Peer Review, Research | 3 | 2021 | 344 | 0.400 |
Why?
|
Heart Failure, Diastolic | 1 | 2012 | 77 | 0.390 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1280 | 0.390 |
Why?
|
Atherosclerosis | 7 | 2014 | 3431 | 0.380 |
Why?
|
Cardiac Volume | 5 | 2012 | 197 | 0.380 |
Why?
|
Radiography, Thoracic | 2 | 2017 | 1320 | 0.370 |
Why?
|
Echocardiography, Three-Dimensional | 8 | 2013 | 614 | 0.370 |
Why?
|
Bariatric Surgery | 2 | 2013 | 1013 | 0.370 |
Why?
|
Pleural Effusion | 1 | 2014 | 344 | 0.360 |
Why?
|
Exercise Test | 7 | 2024 | 2186 | 0.360 |
Why?
|
Retrospective Studies | 44 | 2024 | 81801 | 0.360 |
Why?
|
Plaque, Atherosclerotic | 6 | 2022 | 1548 | 0.360 |
Why?
|
Pandemics | 5 | 2022 | 8753 | 0.350 |
Why?
|
Intra-Abdominal Fat | 2 | 2013 | 624 | 0.350 |
Why?
|
General Practice | 1 | 2011 | 101 | 0.350 |
Why?
|
Diastole | 6 | 2022 | 784 | 0.350 |
Why?
|
American Heart Association | 7 | 2017 | 1051 | 0.340 |
Why?
|
Subcutaneous Fat | 1 | 2013 | 403 | 0.340 |
Why?
|
Risk Factors | 52 | 2024 | 74962 | 0.340 |
Why?
|
Prospective Studies | 48 | 2024 | 54920 | 0.330 |
Why?
|
Weight Loss | 2 | 2013 | 2713 | 0.330 |
Why?
|
Fibrinolytic Agents | 3 | 2012 | 2074 | 0.320 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1813 | 0.320 |
Why?
|
Ambulatory Care Facilities | 1 | 2015 | 941 | 0.320 |
Why?
|
Perception | 1 | 2015 | 1205 | 0.310 |
Why?
|
Acrylic Resins | 1 | 2009 | 135 | 0.310 |
Why?
|
Arrhythmias, Cardiac | 6 | 2024 | 2258 | 0.310 |
Why?
|
Time Factors | 39 | 2024 | 40272 | 0.310 |
Why?
|
Quality Improvement | 3 | 2019 | 3858 | 0.310 |
Why?
|
Liver Diseases | 2 | 2014 | 1304 | 0.300 |
Why?
|
Coronary Artery Bypass | 8 | 2007 | 2194 | 0.300 |
Why?
|
Cardiovascular System | 6 | 2020 | 838 | 0.300 |
Why?
|
Death, Sudden, Cardiac | 6 | 2023 | 1568 | 0.300 |
Why?
|
Ergocalciferols | 4 | 2012 | 110 | 0.300 |
Why?
|
Organ Size | 9 | 2024 | 2268 | 0.290 |
Why?
|
Esophagus | 3 | 2010 | 1042 | 0.290 |
Why?
|
Body Fat Distribution | 1 | 2009 | 246 | 0.290 |
Why?
|
Myocardial Perfusion Imaging | 4 | 2021 | 672 | 0.280 |
Why?
|
Veins | 2 | 2010 | 768 | 0.280 |
Why?
|
Gelatin | 1 | 2009 | 231 | 0.280 |
Why?
|
Pentetic Acid | 4 | 2004 | 209 | 0.280 |
Why?
|
Doxorubicin | 3 | 2024 | 2229 | 0.280 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2007 | 109 | 0.280 |
Why?
|
Societies, Medical | 9 | 2020 | 3960 | 0.280 |
Why?
|
Ultrasonography | 6 | 2021 | 6001 | 0.270 |
Why?
|
Premedication | 2 | 2006 | 246 | 0.270 |
Why?
|
Lung Diseases | 1 | 2017 | 1925 | 0.270 |
Why?
|
Signal Processing, Computer-Assisted | 9 | 2016 | 1496 | 0.270 |
Why?
|
Hypothyroidism | 1 | 2011 | 669 | 0.270 |
Why?
|
Stilbenes | 3 | 2012 | 155 | 0.260 |
Why?
|
Follow-Up Studies | 26 | 2018 | 39407 | 0.260 |
Why?
|
Hyperventilation | 2 | 2013 | 78 | 0.260 |
Why?
|
Antibiotic Prophylaxis | 2 | 2002 | 640 | 0.260 |
Why?
|
Diagnostic Imaging | 3 | 2017 | 3541 | 0.260 |
Why?
|
Hypertension | 8 | 2019 | 8615 | 0.260 |
Why?
|
Health Status Indicators | 2 | 2010 | 971 | 0.250 |
Why?
|
Cheyne-Stokes Respiration | 1 | 2005 | 38 | 0.250 |
Why?
|
Endomyocardial Fibrosis | 2 | 2020 | 41 | 0.250 |
Why?
|
Leadership | 3 | 2021 | 1395 | 0.250 |
Why?
|
Inflammation Mediators | 2 | 2013 | 1890 | 0.250 |
Why?
|
Heart Conduction System | 3 | 2019 | 1009 | 0.250 |
Why?
|
Body Surface Area | 2 | 2024 | 206 | 0.250 |
Why?
|
Sex Factors | 10 | 2018 | 10654 | 0.250 |
Why?
|
Case-Control Studies | 21 | 2019 | 22296 | 0.240 |
Why?
|
Aorta | 6 | 2013 | 2046 | 0.240 |
Why?
|
Motion | 12 | 2014 | 789 | 0.240 |
Why?
|
Obesity | 8 | 2016 | 13084 | 0.240 |
Why?
|
Registries | 3 | 2019 | 8379 | 0.230 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 2007 | 539 | 0.230 |
Why?
|
Heart Rate | 9 | 2019 | 4218 | 0.230 |
Why?
|
Severity of Illness Index | 15 | 2019 | 15939 | 0.230 |
Why?
|
Myocardial Ischemia | 6 | 2013 | 2139 | 0.230 |
Why?
|
Dobutamine | 1 | 2004 | 116 | 0.230 |
Why?
|
Acute Disease | 6 | 2023 | 7242 | 0.220 |
Why?
|
Tachycardia, Ventricular | 4 | 2017 | 1309 | 0.220 |
Why?
|
Heart Valve Prosthesis | 3 | 2013 | 1468 | 0.210 |
Why?
|
Benzocaine | 1 | 2003 | 14 | 0.210 |
Why?
|
Treatment Outcome | 24 | 2022 | 65379 | 0.210 |
Why?
|
Quality of Health Care | 2 | 2015 | 4339 | 0.210 |
Why?
|
Swine, Miniature | 2 | 2024 | 965 | 0.210 |
Why?
|
Risk Assessment | 23 | 2024 | 24318 | 0.210 |
Why?
|
Postoperative Period | 4 | 2018 | 1830 | 0.210 |
Why?
|
Pulmonary Artery | 4 | 2020 | 1945 | 0.210 |
Why?
|
Primary Prevention | 3 | 2024 | 1187 | 0.210 |
Why?
|
Surgery, Computer-Assisted | 2 | 2008 | 1006 | 0.210 |
Why?
|
Methemoglobinemia | 1 | 2003 | 45 | 0.210 |
Why?
|
Radiation Injuries | 3 | 2002 | 1204 | 0.210 |
Why?
|
Graft Occlusion, Vascular | 2 | 2003 | 538 | 0.210 |
Why?
|
Tricuspid Valve | 3 | 2020 | 419 | 0.200 |
Why?
|
Postoperative Care | 1 | 2009 | 1480 | 0.200 |
Why?
|
Academic Medical Centers | 3 | 2019 | 2783 | 0.200 |
Why?
|
Radiographic Image Enhancement | 2 | 2004 | 877 | 0.200 |
Why?
|
Adipose Tissue | 5 | 2018 | 3334 | 0.200 |
Why?
|
Radiology | 2 | 2014 | 2117 | 0.200 |
Why?
|
Data Compression | 2 | 2014 | 69 | 0.200 |
Why?
|
Evidence-Based Medicine | 3 | 2012 | 3707 | 0.200 |
Why?
|
Echocardiography, Stress | 1 | 2003 | 139 | 0.200 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2022 | 452 | 0.190 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2024 | 3781 | 0.190 |
Why?
|
Inhalation | 1 | 2002 | 145 | 0.190 |
Why?
|
Advisory Committees | 4 | 2019 | 797 | 0.190 |
Why?
|
Thoracic Surgery | 2 | 2017 | 727 | 0.190 |
Why?
|
Prevalence | 16 | 2022 | 15872 | 0.190 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2013 | 353 | 0.180 |
Why?
|
Cardiotonic Agents | 1 | 2004 | 544 | 0.180 |
Why?
|
Tricuspid Valve Prolapse | 1 | 2020 | 6 | 0.180 |
Why?
|
Amyloidosis | 1 | 2008 | 879 | 0.180 |
Why?
|
Injections, Intravenous | 3 | 2012 | 1379 | 0.180 |
Why?
|
Patient Compliance | 2 | 2002 | 2693 | 0.180 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2006 | 470 | 0.180 |
Why?
|
Age Factors | 12 | 2024 | 18471 | 0.180 |
Why?
|
Subtraction Technique | 2 | 2014 | 519 | 0.180 |
Why?
|
Disease Progression | 8 | 2024 | 13646 | 0.180 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 824 | 0.180 |
Why?
|
Adiposity | 2 | 2018 | 1895 | 0.180 |
Why?
|
Cohort Studies | 21 | 2022 | 41795 | 0.170 |
Why?
|
Ambulatory Care | 1 | 2011 | 2784 | 0.170 |
Why?
|
Angioplasty, Balloon, Coronary | 5 | 2010 | 1724 | 0.170 |
Why?
|
Heparin, Low-Molecular-Weight | 3 | 2008 | 344 | 0.170 |
Why?
|
Cardiac Output, Low | 2 | 2015 | 191 | 0.170 |
Why?
|
Allied Health Personnel | 1 | 2021 | 156 | 0.170 |
Why?
|
Prone Position | 1 | 2001 | 203 | 0.170 |
Why?
|
Dextrocardia | 1 | 1999 | 37 | 0.170 |
Why?
|
Hypertension, Pulmonary | 1 | 2010 | 1597 | 0.170 |
Why?
|
Ventricular Outflow Obstruction | 6 | 2014 | 262 | 0.170 |
Why?
|
Situs Inversus | 1 | 1999 | 63 | 0.160 |
Why?
|
Stents | 8 | 2007 | 3201 | 0.160 |
Why?
|
Postoperative Complications | 5 | 2017 | 15881 | 0.160 |
Why?
|
Massachusetts | 10 | 2016 | 8902 | 0.160 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1410 | 0.160 |
Why?
|
Swine | 10 | 2024 | 5994 | 0.160 |
Why?
|
Feasibility Studies | 12 | 2022 | 5313 | 0.160 |
Why?
|
Embolism | 1 | 2022 | 401 | 0.160 |
Why?
|
Practice Guidelines as Topic | 7 | 2020 | 7453 | 0.160 |
Why?
|
Heparin | 6 | 2006 | 1636 | 0.160 |
Why?
|
Kidney Diseases | 3 | 2017 | 2103 | 0.150 |
Why?
|
Bone Density Conservation Agents | 3 | 2012 | 797 | 0.150 |
Why?
|
Analysis of Variance | 8 | 2014 | 6241 | 0.150 |
Why?
|
Boston | 4 | 2019 | 9371 | 0.150 |
Why?
|
Animals | 35 | 2024 | 169337 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 7 | 2016 | 6541 | 0.150 |
Why?
|
Troponin T | 2 | 2021 | 787 | 0.150 |
Why?
|
Endocarditis | 1 | 2002 | 352 | 0.150 |
Why?
|
Extracellular Matrix | 2 | 2024 | 1739 | 0.150 |
Why?
|
Cross-Sectional Studies | 11 | 2022 | 26375 | 0.150 |
Why?
|
Linear Models | 9 | 2016 | 5878 | 0.150 |
Why?
|
Bibliometrics | 2 | 2018 | 355 | 0.150 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1997 | 144 | 0.140 |
Why?
|
Heart Neoplasms | 2 | 2009 | 374 | 0.140 |
Why?
|
Decision Trees | 1 | 1999 | 509 | 0.140 |
Why?
|
International Normalized Ratio | 3 | 2012 | 382 | 0.140 |
Why?
|
Workers' Compensation | 1 | 2017 | 150 | 0.140 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2017 | 63 | 0.140 |
Why?
|
United States | 27 | 2022 | 73150 | 0.140 |
Why?
|
Cardiac Surgical Procedures | 2 | 2016 | 3681 | 0.140 |
Why?
|
Vasodilator Agents | 2 | 2012 | 990 | 0.130 |
Why?
|
Cardiac Myosins | 1 | 2017 | 128 | 0.130 |
Why?
|
Sus scrofa | 5 | 2019 | 430 | 0.130 |
Why?
|
Vitamin K | 3 | 2012 | 314 | 0.130 |
Why?
|
Pulmonary Ventilation | 1 | 1998 | 376 | 0.130 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2019 | 554 | 0.130 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2009 | 429 | 0.130 |
Why?
|
Single-Blind Method | 3 | 2014 | 1585 | 0.130 |
Why?
|
Endocarditis, Bacterial | 1 | 2000 | 436 | 0.130 |
Why?
|
Leukoaraiosis | 1 | 2017 | 115 | 0.130 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2015 | 30 | 0.130 |
Why?
|
Anesthetics, Local | 1 | 2003 | 1004 | 0.130 |
Why?
|
Pilot Projects | 9 | 2021 | 8731 | 0.130 |
Why?
|
Thorax | 3 | 2009 | 559 | 0.130 |
Why?
|
Coronary Care Units | 1 | 2017 | 235 | 0.120 |
Why?
|
Angina Pectoris | 1 | 2019 | 960 | 0.120 |
Why?
|
Myosin Heavy Chains | 1 | 2017 | 404 | 0.120 |
Why?
|
Albuminuria | 2 | 2017 | 658 | 0.120 |
Why?
|
Statistics, Nonparametric | 4 | 2012 | 2862 | 0.120 |
Why?
|
Body Surface Potential Mapping | 2 | 2014 | 228 | 0.120 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 1995 | 48 | 0.120 |
Why?
|
Cause of Death | 2 | 2020 | 3728 | 0.120 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2016 | 163 | 0.120 |
Why?
|
Oxygen Inhalation Therapy | 1 | 1998 | 417 | 0.120 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2020 | 579 | 0.120 |
Why?
|
Ventricular Septum | 1 | 2015 | 76 | 0.120 |
Why?
|
Phenotype | 10 | 2017 | 16721 | 0.120 |
Why?
|
Sarcoidosis | 1 | 2020 | 534 | 0.120 |
Why?
|
Proportional Hazards Models | 5 | 2015 | 12558 | 0.120 |
Why?
|
Cardiac Output | 3 | 2012 | 838 | 0.120 |
Why?
|
Blood | 1 | 2017 | 597 | 0.120 |
Why?
|
Awards and Prizes | 1 | 2018 | 365 | 0.120 |
Why?
|
Magnetics | 3 | 2011 | 599 | 0.120 |
Why?
|
Medicare | 4 | 2022 | 6881 | 0.110 |
Why?
|
Anatomy, Cross-Sectional | 2 | 2006 | 139 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2022 | 954 | 0.110 |
Why?
|
Phlebography | 1 | 2015 | 326 | 0.110 |
Why?
|
Diagnosis, Differential | 8 | 2019 | 13020 | 0.110 |
Why?
|
Recurrence | 7 | 2018 | 8506 | 0.110 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 390 | 0.110 |
Why?
|
Cerebrovascular Disorders | 2 | 1998 | 1486 | 0.110 |
Why?
|
Chi-Square Distribution | 4 | 2016 | 3438 | 0.110 |
Why?
|
Fibrin | 3 | 2005 | 514 | 0.110 |
Why?
|
Syndrome | 1 | 2019 | 3275 | 0.110 |
Why?
|
Multivariate Analysis | 8 | 2016 | 12092 | 0.110 |
Why?
|
Ventricular Function | 2 | 2013 | 406 | 0.110 |
Why?
|
Exercise | 2 | 2024 | 5946 | 0.110 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18362 | 0.100 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2013 | 184 | 0.100 |
Why?
|
Body Mass Index | 6 | 2013 | 13052 | 0.100 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2661 | 0.100 |
Why?
|
Inpatients | 2 | 2016 | 2570 | 0.100 |
Why?
|
Radiation Dosage | 4 | 2013 | 1974 | 0.100 |
Why?
|
Conflict of Interest | 1 | 2017 | 555 | 0.100 |
Why?
|
Physicians, Women | 1 | 2018 | 520 | 0.100 |
Why?
|
Brain | 5 | 2017 | 27454 | 0.100 |
Why?
|
Body Water | 1 | 2013 | 340 | 0.100 |
Why?
|
Respiratory Physiological Phenomena | 2 | 2006 | 192 | 0.100 |
Why?
|
Young Adult | 18 | 2024 | 60049 | 0.100 |
Why?
|
User-Computer Interface | 3 | 2006 | 1397 | 0.100 |
Why?
|
Chronic Disease | 3 | 2019 | 9379 | 0.100 |
Why?
|
Databases, Factual | 3 | 2018 | 8075 | 0.100 |
Why?
|
Receptors, Calcitriol | 2 | 2011 | 361 | 0.100 |
Why?
|
Action Potentials | 1 | 2019 | 1838 | 0.090 |
Why?
|
Wavelet Analysis | 1 | 2011 | 56 | 0.090 |
Why?
|
Comorbidity | 4 | 2014 | 10588 | 0.090 |
Why?
|
Heart Septal Defects | 1 | 1992 | 191 | 0.090 |
Why?
|
Personnel, Hospital | 1 | 2013 | 285 | 0.090 |
Why?
|
Angiography | 4 | 2020 | 1598 | 0.090 |
Why?
|
Biometry | 1 | 2014 | 565 | 0.090 |
Why?
|
Diltiazem | 1 | 1991 | 132 | 0.090 |
Why?
|
Equipment Design | 5 | 2014 | 3529 | 0.090 |
Why?
|
Cholelithiasis | 1 | 2012 | 408 | 0.090 |
Why?
|
Diabetic Nephropathies | 2 | 2008 | 975 | 0.090 |
Why?
|
Isosorbide Dinitrate | 1 | 2010 | 34 | 0.090 |
Why?
|
Foundations | 1 | 2010 | 96 | 0.080 |
Why?
|
Adolescent | 20 | 2019 | 89184 | 0.080 |
Why?
|
Utilization Review | 1 | 2011 | 384 | 0.080 |
Why?
|
Administration, Oral | 4 | 2012 | 4039 | 0.080 |
Why?
|
Incidence | 7 | 2022 | 21544 | 0.080 |
Why?
|
Mitral Valve Stenosis | 1 | 1992 | 342 | 0.080 |
Why?
|
Blood Pressure | 7 | 2012 | 8541 | 0.080 |
Why?
|
Ventricular Dysfunction | 1 | 2010 | 144 | 0.080 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2015 | 559 | 0.080 |
Why?
|
Anthropometry | 1 | 2014 | 1343 | 0.080 |
Why?
|
Vascular System Injuries | 1 | 2013 | 248 | 0.080 |
Why?
|
Septal Occluder Device | 1 | 2010 | 125 | 0.080 |
Why?
|
Bioprosthesis | 1 | 2013 | 592 | 0.080 |
Why?
|
Calcinosis | 4 | 2011 | 1481 | 0.080 |
Why?
|
Recovery of Function | 1 | 2019 | 2990 | 0.080 |
Why?
|
Vena Cava, Superior | 1 | 2009 | 197 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1568 | 0.080 |
Why?
|
Breast | 1 | 1997 | 1975 | 0.080 |
Why?
|
Computer Systems | 3 | 2013 | 470 | 0.080 |
Why?
|
Rheology | 1 | 2009 | 348 | 0.080 |
Why?
|
Survival Rate | 5 | 2016 | 12870 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2019 | 1141 | 0.080 |
Why?
|
Radiography | 4 | 2024 | 6993 | 0.080 |
Why?
|
Hernia, Hiatal | 1 | 2009 | 90 | 0.080 |
Why?
|
Fumarates | 1 | 2009 | 132 | 0.080 |
Why?
|
Testosterone | 1 | 2019 | 2493 | 0.070 |
Why?
|
Cardiovascular Physiological Phenomena | 2 | 2006 | 241 | 0.070 |
Why?
|
Myocytes, Cardiac | 4 | 2004 | 1685 | 0.070 |
Why?
|
Longitudinal Studies | 7 | 2022 | 14784 | 0.070 |
Why?
|
Foramen Ovale, Patent | 1 | 2010 | 210 | 0.070 |
Why?
|
Glycemic Index | 1 | 2010 | 400 | 0.070 |
Why?
|
Valine | 1 | 2009 | 410 | 0.070 |
Why?
|
Anesthesiology | 1 | 2017 | 1137 | 0.070 |
Why?
|
Fourier Analysis | 2 | 1999 | 440 | 0.070 |
Why?
|
Internet | 2 | 2020 | 3107 | 0.070 |
Why?
|
Losartan | 1 | 2009 | 263 | 0.070 |
Why?
|
Dyspnea | 2 | 2013 | 1351 | 0.070 |
Why?
|
Adenosine | 1 | 2012 | 817 | 0.070 |
Why?
|
Angioplasty, Balloon | 1 | 1991 | 592 | 0.070 |
Why?
|
Electrophysiologic Techniques, Cardiac | 2 | 2020 | 511 | 0.070 |
Why?
|
Hemangioma | 1 | 2012 | 727 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2020 | 1891 | 0.070 |
Why?
|
Injections, Subcutaneous | 1 | 2008 | 687 | 0.070 |
Why?
|
Cysts | 1 | 2012 | 685 | 0.070 |
Why?
|
Area Under Curve | 2 | 2016 | 1642 | 0.070 |
Why?
|
Supine Position | 2 | 2019 | 208 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1758 | 0.070 |
Why?
|
Tomography | 1 | 2009 | 442 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3312 | 0.070 |
Why?
|
Catheterization | 1 | 1992 | 1431 | 0.070 |
Why?
|
Kidney Failure, Chronic | 2 | 2011 | 2491 | 0.070 |
Why?
|
Science | 1 | 2009 | 237 | 0.070 |
Why?
|
Sex Distribution | 3 | 2013 | 2281 | 0.070 |
Why?
|
Amides | 1 | 2009 | 452 | 0.070 |
Why?
|
Water | 1 | 2012 | 1418 | 0.060 |
Why?
|
Carotid Artery, Common | 1 | 2006 | 175 | 0.060 |
Why?
|
Medical Staff Privileges | 1 | 2005 | 13 | 0.060 |
Why?
|
Tea | 1 | 2007 | 289 | 0.060 |
Why?
|
China | 1 | 2012 | 2395 | 0.060 |
Why?
|
Tachycardia | 1 | 2008 | 598 | 0.060 |
Why?
|
Age Distribution | 3 | 2013 | 2877 | 0.060 |
Why?
|
Cardiomegaly | 2 | 2003 | 591 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 1 | 2011 | 1196 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2005 | 1459 | 0.060 |
Why?
|
Odds Ratio | 4 | 2024 | 9682 | 0.060 |
Why?
|
Child | 12 | 2019 | 80891 | 0.060 |
Why?
|
Connexin 43 | 2 | 2003 | 202 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2931 | 0.060 |
Why?
|
Aspirin | 3 | 2012 | 3135 | 0.060 |
Why?
|
Muscles | 1 | 2009 | 1582 | 0.060 |
Why?
|
Clinical Trials as Topic | 4 | 2005 | 8051 | 0.060 |
Why?
|
Genetic Loci | 1 | 2014 | 2630 | 0.060 |
Why?
|
Elasticity | 2 | 2005 | 657 | 0.060 |
Why?
|
Athletes | 1 | 2012 | 1162 | 0.060 |
Why?
|
Education, Medical, Graduate | 2 | 2008 | 2412 | 0.060 |
Why?
|
Tooth Extraction | 1 | 2006 | 229 | 0.060 |
Why?
|
Heart Block | 1 | 2006 | 390 | 0.060 |
Why?
|
Neuregulin-1 | 1 | 2005 | 136 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1673 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2002 | 21162 | 0.060 |
Why?
|
Wrestling | 1 | 2003 | 19 | 0.060 |
Why?
|
Diabetic Angiopathies | 1 | 2009 | 806 | 0.060 |
Why?
|
Renal Artery | 2 | 2002 | 353 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 4936 | 0.050 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2003 | 61 | 0.050 |
Why?
|
Glomerular Filtration Rate | 4 | 2017 | 2226 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2014 | 2660 | 0.050 |
Why?
|
Vitamins | 1 | 2012 | 1637 | 0.050 |
Why?
|
Movement | 3 | 2015 | 1490 | 0.050 |
Why?
|
Acute Coronary Syndrome | 1 | 2016 | 2192 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2012 | 1751 | 0.050 |
Why?
|
Models, Animal | 3 | 2005 | 2124 | 0.050 |
Why?
|
Thrombolytic Therapy | 2 | 2009 | 2050 | 0.050 |
Why?
|
Hemodynamics | 5 | 2005 | 4199 | 0.050 |
Why?
|
Tetrazoles | 1 | 2009 | 923 | 0.050 |
Why?
|
Biopsy | 2 | 2024 | 6808 | 0.050 |
Why?
|
Double-Blind Method | 6 | 2016 | 12456 | 0.050 |
Why?
|
Europe | 3 | 2017 | 3439 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1371 | 0.050 |
Why?
|
Safety | 1 | 2007 | 1159 | 0.050 |
Why?
|
Peptide Hormones | 1 | 2004 | 132 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 12241 | 0.050 |
Why?
|
ROC Curve | 2 | 2016 | 3623 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2008 | 10377 | 0.050 |
Why?
|
Homeodomain Proteins | 2 | 2003 | 2429 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2008 | 3440 | 0.050 |
Why?
|
Treatment Failure | 1 | 2009 | 2663 | 0.050 |
Why?
|
Peptides | 2 | 2005 | 4353 | 0.050 |
Why?
|
Radionuclide Imaging | 3 | 2013 | 1998 | 0.050 |
Why?
|
Heart Transplantation | 1 | 1996 | 3300 | 0.050 |
Why?
|
Abdomen | 2 | 1999 | 1136 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1389 | 0.050 |
Why?
|
Xenopus Proteins | 2 | 2003 | 435 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7064 | 0.050 |
Why?
|
Oxygen | 1 | 2013 | 4273 | 0.050 |
Why?
|
Calcium-Transporting ATPases | 1 | 2001 | 122 | 0.050 |
Why?
|
Renal Artery Obstruction | 1 | 2002 | 218 | 0.050 |
Why?
|
Mass Screening | 2 | 2012 | 5451 | 0.050 |
Why?
|
Alzheimer Disease | 2 | 2015 | 8747 | 0.050 |
Why?
|
Sinoatrial Node | 1 | 2001 | 99 | 0.050 |
Why?
|
California | 1 | 2005 | 1443 | 0.050 |
Why?
|
Hospitals | 1 | 2014 | 3906 | 0.050 |
Why?
|
Nephrectomy | 1 | 2006 | 949 | 0.050 |
Why?
|
Principal Component Analysis | 1 | 2024 | 948 | 0.050 |
Why?
|
Fibrinogen | 1 | 2004 | 891 | 0.040 |
Why?
|
Bayes Theorem | 2 | 2024 | 2353 | 0.040 |
Why?
|
Atrioventricular Node | 1 | 2001 | 180 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3922 | 0.040 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1133 | 0.040 |
Why?
|
Tunica Media | 1 | 2000 | 111 | 0.040 |
Why?
|
Myocardial Revascularization | 1 | 2004 | 796 | 0.040 |
Why?
|
Equipment Failure Analysis | 2 | 2014 | 848 | 0.040 |
Why?
|
Dementia | 1 | 2015 | 2729 | 0.040 |
Why?
|
Sarcomeres | 1 | 2003 | 380 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2024 | 677 | 0.040 |
Why?
|
Procainamide | 1 | 1999 | 56 | 0.040 |
Why?
|
Pharynx | 1 | 2003 | 436 | 0.040 |
Why?
|
Models, Theoretical | 3 | 2017 | 3579 | 0.040 |
Why?
|
Edema | 2 | 2014 | 766 | 0.040 |
Why?
|
Ethanol | 1 | 2006 | 1332 | 0.040 |
Why?
|
Periodicity | 1 | 2001 | 348 | 0.040 |
Why?
|
Colonoscopy | 2 | 2006 | 1412 | 0.040 |
Why?
|
Models, Structural | 1 | 2000 | 340 | 0.040 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 1303 | 0.040 |
Why?
|
Oximetry | 1 | 2003 | 462 | 0.040 |
Why?
|
Rats, Inbred Strains | 2 | 1991 | 2087 | 0.040 |
Why?
|
C-Reactive Protein | 3 | 2011 | 3857 | 0.040 |
Why?
|
Infarction | 1 | 2020 | 247 | 0.040 |
Why?
|
Mice | 9 | 2005 | 82017 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2009 | 2027 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2006 | 2728 | 0.040 |
Why?
|
Leptin | 2 | 2004 | 1597 | 0.040 |
Why?
|
Arteries | 3 | 2006 | 1126 | 0.040 |
Why?
|
Rabbits | 2 | 2004 | 4781 | 0.040 |
Why?
|
Oscillometry | 1 | 1999 | 150 | 0.040 |
Why?
|
Insurance Claim Reporting | 1 | 1999 | 166 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2004 | 1445 | 0.040 |
Why?
|
Survival Analysis | 2 | 2009 | 10117 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 534 | 0.040 |
Why?
|
Independent Living | 1 | 2022 | 580 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2296 | 0.040 |
Why?
|
Medicare Part B | 1 | 1999 | 117 | 0.040 |
Why?
|
Tissue Survival | 1 | 2018 | 120 | 0.040 |
Why?
|
Cholesterol | 2 | 2011 | 2912 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6670 | 0.040 |
Why?
|
Chest Pain | 1 | 2005 | 1099 | 0.040 |
Why?
|
Colon | 1 | 2006 | 1805 | 0.040 |
Why?
|
Carotid Stenosis | 1 | 2005 | 862 | 0.040 |
Why?
|
False Negative Reactions | 2 | 2012 | 575 | 0.040 |
Why?
|
Feedback | 1 | 2021 | 795 | 0.040 |
Why?
|
Glucose Tolerance Test | 2 | 2011 | 1183 | 0.040 |
Why?
|
Logistic Models | 4 | 2016 | 13323 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10776 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2002 | 3627 | 0.030 |
Why?
|
Patient Selection | 3 | 2016 | 4266 | 0.030 |
Why?
|
Heart-Assist Devices | 1 | 2007 | 1292 | 0.030 |
Why?
|
Patient Positioning | 1 | 2019 | 332 | 0.030 |
Why?
|
Computer Graphics | 1 | 1998 | 338 | 0.030 |
Why?
|
Quebec | 1 | 2016 | 139 | 0.030 |
Why?
|
Anisotropy | 1 | 2000 | 1296 | 0.030 |
Why?
|
Atrial Function | 1 | 1996 | 99 | 0.030 |
Why?
|
Radio Waves | 1 | 1997 | 254 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2010 | 3981 | 0.030 |
Why?
|
Mutation | 3 | 2017 | 30228 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1997 | 881 | 0.030 |
Why?
|
Collagen | 1 | 2024 | 2646 | 0.030 |
Why?
|
Sirolimus | 1 | 2003 | 1542 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1999 | 775 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2013 | 4427 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2008 | 5151 | 0.030 |
Why?
|
Risk | 2 | 2013 | 9636 | 0.030 |
Why?
|
Time | 1 | 2017 | 546 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2000 | 1727 | 0.030 |
Why?
|
Intraoperative Period | 1 | 1995 | 513 | 0.030 |
Why?
|
Prosthesis Design | 2 | 2013 | 2126 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 16028 | 0.030 |
Why?
|
Curriculum | 1 | 2008 | 3776 | 0.030 |
Why?
|
Cell Survival | 1 | 2004 | 5792 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2010 | 5891 | 0.030 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2014 | 118 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2019 | 1195 | 0.030 |
Why?
|
Tomography, Spiral Computed | 2 | 2006 | 274 | 0.030 |
Why?
|
Computer Simulation | 3 | 2010 | 6277 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 494 | 0.030 |
Why?
|
Cost-Benefit Analysis | 3 | 2004 | 5538 | 0.030 |
Why?
|
Probability | 1 | 1999 | 2482 | 0.030 |
Why?
|
Cognition | 1 | 2011 | 7075 | 0.030 |
Why?
|
Creatinine | 2 | 2011 | 1915 | 0.030 |
Why?
|
Medical History Taking | 1 | 1997 | 776 | 0.030 |
Why?
|
Access to Information | 1 | 2016 | 317 | 0.030 |
Why?
|
Anesthesia, Conduction | 1 | 1996 | 263 | 0.030 |
Why?
|
Polysomnography | 1 | 2020 | 1865 | 0.030 |
Why?
|
Inflammation | 2 | 2011 | 10863 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2013 | 365 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2003 | 1309 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 1999 | 1735 | 0.030 |
Why?
|
Transcription Factors | 2 | 2003 | 12166 | 0.030 |
Why?
|
Rats | 5 | 2003 | 23835 | 0.020 |
Why?
|
Atrophy | 1 | 2017 | 1648 | 0.020 |
Why?
|
Device Removal | 1 | 2017 | 643 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 1997 | 877 | 0.020 |
Why?
|
Minnesota | 1 | 2012 | 338 | 0.020 |
Why?
|
Population Surveillance | 1 | 2002 | 2598 | 0.020 |
Why?
|
beta-Alanine | 1 | 2012 | 82 | 0.020 |
Why?
|
Genotype | 3 | 2014 | 13042 | 0.020 |
Why?
|
Canada | 1 | 2017 | 2139 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2000 | 1680 | 0.020 |
Why?
|
Physical Examination | 1 | 1997 | 1262 | 0.020 |
Why?
|
Cross-Over Studies | 2 | 2009 | 2106 | 0.020 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2012 | 125 | 0.020 |
Why?
|
Italy | 1 | 2013 | 854 | 0.020 |
Why?
|
Glucose Transporter Type 4 | 1 | 2011 | 241 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 163 | 0.020 |
Why?
|
Angiostatins | 1 | 2010 | 64 | 0.020 |
Why?
|
Normal Distribution | 1 | 2011 | 272 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2011 | 368 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2015 | 710 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2003 | 6234 | 0.020 |
Why?
|
Software | 2 | 2002 | 4453 | 0.020 |
Why?
|
Blotting, Western | 2 | 2012 | 5037 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6318 | 0.020 |
Why?
|
Muscle Cells | 1 | 2011 | 195 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 589 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2018 | 1218 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2010 | 60 | 0.020 |
Why?
|
Forecasting | 1 | 1999 | 2948 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2013 | 993 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 2010 | 224 | 0.020 |
Why?
|
Mice, Transgenic | 4 | 2003 | 9562 | 0.020 |
Why?
|
Sleep | 1 | 2005 | 4802 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 394 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2010 | 318 | 0.020 |
Why?
|
Vasculitis | 1 | 2013 | 524 | 0.020 |
Why?
|
Anesthesia, General | 1 | 1996 | 1186 | 0.020 |
Why?
|
Hypercalcemia | 1 | 2012 | 423 | 0.020 |
Why?
|
Collateral Circulation | 1 | 2010 | 291 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 1990 | 826 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2011 | 579 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3212 | 0.020 |
Why?
|
Blood Volume | 1 | 1990 | 546 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2016 | 1422 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2010 | 195 | 0.020 |
Why?
|
Endocardium | 1 | 2009 | 249 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1137 | 0.020 |
Why?
|
Emergencies | 1 | 1995 | 1219 | 0.020 |
Why?
|
Heart Defects, Congenital | 2 | 2004 | 4713 | 0.020 |
Why?
|
Child, Preschool | 3 | 2006 | 42650 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2475 | 0.020 |
Why?
|
Sample Size | 1 | 2011 | 848 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2013 | 1208 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 1996 | 4834 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2742 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2009 | 463 | 0.020 |
Why?
|
Ticlopidine | 1 | 2012 | 730 | 0.020 |
Why?
|
Ventricular Premature Complexes | 1 | 2008 | 112 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2010 | 1104 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 586 | 0.020 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2008 | 153 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2012 | 864 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2003 | 5708 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3413 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4544 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2008 | 252 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2016 | 2006 | 0.020 |
Why?
|
Drug Combinations | 1 | 1992 | 2079 | 0.020 |
Why?
|
Insulin | 2 | 2011 | 6607 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2226 | 0.020 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2009 | 484 | 0.020 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2010 | 881 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4120 | 0.020 |
Why?
|
Cadherins | 1 | 2010 | 906 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1997 | 2763 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1958 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2012 | 1804 | 0.020 |
Why?
|
Models, Biological | 1 | 2001 | 9493 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 1997 | 8562 | 0.020 |
Why?
|
Credentialing | 1 | 2005 | 114 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2225 | 0.020 |
Why?
|
Blood Glucose | 2 | 2010 | 6430 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 2004 | 181 | 0.010 |
Why?
|
Preoperative Care | 1 | 2013 | 2258 | 0.010 |
Why?
|
Tissue Distribution | 2 | 2002 | 2299 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 612 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 18048 | 0.010 |
Why?
|
Myosin Light Chains | 1 | 2003 | 122 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2003 | 71 | 0.010 |
Why?
|
Ribosomal Protein S6 | 1 | 2003 | 70 | 0.010 |
Why?
|
Constriction | 1 | 2003 | 168 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2010 | 1322 | 0.010 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2003 | 103 | 0.010 |
Why?
|
Microcirculation | 1 | 2008 | 1282 | 0.010 |
Why?
|
Drug-Eluting Stents | 1 | 2009 | 681 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 1244 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2004 | 1142 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6856 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 2003 | 527 | 0.010 |
Why?
|
Ghrelin | 1 | 2004 | 251 | 0.010 |
Why?
|
Quality Control | 1 | 2004 | 833 | 0.010 |
Why?
|
Lung | 1 | 2000 | 10089 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2004 | 962 | 0.010 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2001 | 90 | 0.010 |
Why?
|
Placebos | 1 | 2005 | 1668 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3139 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2003 | 414 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2708 | 0.010 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2001 | 132 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2004 | 1755 | 0.010 |
Why?
|
Educational Measurement | 1 | 2008 | 1256 | 0.010 |
Why?
|
Heart Septum | 1 | 2002 | 304 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3345 | 0.010 |
Why?
|
Thinness | 1 | 2004 | 483 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2060 | 0.010 |
Why?
|
Foreign-Body Migration | 1 | 2002 | 220 | 0.010 |
Why?
|
Education, Medical, Continuing | 1 | 2005 | 829 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36510 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2003 | 2559 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2734 | 0.010 |
Why?
|
Hemorrhage | 1 | 2012 | 3461 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2011 | 11918 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4031 | 0.010 |
Why?
|
Species Specificity | 1 | 2004 | 2417 | 0.010 |
Why?
|
Connexins | 1 | 2001 | 355 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1999 | 6971 | 0.010 |
Why?
|
Japan | 1 | 2003 | 1418 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2005 | 14481 | 0.010 |
Why?
|
Barium Sulfate | 1 | 1999 | 180 | 0.010 |
Why?
|
Sigmoidoscopy | 1 | 1999 | 151 | 0.010 |
Why?
|
Enema | 1 | 1999 | 141 | 0.010 |
Why?
|
Adenoviridae | 1 | 2003 | 1096 | 0.010 |
Why?
|
Injections | 1 | 2002 | 840 | 0.010 |
Why?
|
Michigan | 1 | 1999 | 341 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2011 | 7145 | 0.010 |
Why?
|
Heterozygote | 1 | 2005 | 2791 | 0.010 |
Why?
|
Teaching | 1 | 2006 | 1172 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2011 | 3443 | 0.010 |
Why?
|
Plasmids | 1 | 2003 | 2268 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 9111 | 0.010 |
Why?
|
Rest | 1 | 2002 | 951 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2001 | 1084 | 0.010 |
Why?
|
Postmenopause | 1 | 2005 | 2518 | 0.010 |
Why?
|
Models, Statistical | 1 | 2011 | 5099 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2002 | 984 | 0.010 |
Why?
|
Posture | 1 | 2000 | 956 | 0.010 |
Why?
|
Protein Kinases | 1 | 2003 | 1609 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2001 | 2695 | 0.010 |
Why?
|
Fetus | 1 | 2003 | 1883 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2004 | 1161 | 0.010 |
Why?
|
Genetic Testing | 1 | 2008 | 3587 | 0.010 |
Why?
|
Rana catesbeiana | 1 | 1994 | 85 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12778 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2005 | 2588 | 0.010 |
Why?
|
Down-Regulation | 1 | 2001 | 2940 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2003 | 2066 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2003 | 3413 | 0.010 |
Why?
|
Diet | 1 | 2011 | 8090 | 0.010 |
Why?
|
Models, Chemical | 1 | 1994 | 611 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5801 | 0.010 |
Why?
|
Phosphorylation | 1 | 2003 | 8326 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2003 | 3458 | 0.010 |
Why?
|
Gene Expression | 1 | 2003 | 7598 | 0.010 |
Why?
|
Body Weight | 1 | 2001 | 4629 | 0.010 |
Why?
|
Regression Analysis | 1 | 1998 | 6350 | 0.000 |
Why?
|
Cattle | 1 | 1994 | 3826 | 0.000 |
Why?
|
Calcium | 1 | 2001 | 5794 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2003 | 12805 | 0.000 |
Why?
|
Cartilage, Articular | 1 | 1994 | 1104 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1999 | 7861 | 0.000 |
Why?
|
Brain Ischemia | 1 | 1998 | 3008 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 8199 | 0.000 |
Why?
|
Signal Transduction | 1 | 2005 | 23631 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 1999 | 5512 | 0.000 |
Why?
|